Water Retention with Long-Term Low-Dose Prednisone

High-Risk Populations Requiring Careful Monitoring

The European Society of Cardiology states that corticosteroids are contraindicated in NYHA class III-IV heart failure but may be considered in class I-II with careful monitoring for fluid retention 1
Heart failure patients with renal dysfunction often have excessive salt and water retention requiring intensive diuretic therapy 1
Fluid retention can diminish response to ACE inhibitors and increase risks with beta-blocker therapy 2, 3

The ACC/AHA guidelines recommend blood pressure targets <130/80 mmHg in CKD patients, which can be compromised by corticosteroid-induced sodium retention 4
Patients with impaired renal function have reduced clearance of sodium and are more susceptible to volume overload 5
Renal transplant patients are particularly vulnerable, as immunosuppressive corticosteroids combined with impaired renal function cause relative salt and water retention 5
Corticosteroid-induced hypertension may require adjustment of antihypertensive medication doses 5

For patients requiring long-term low-dose prednisone, baseline assessment should include documentation of weight, blood pressure, and presence of edema, as well as assessment for heart failure, hypertension, or CKD 1, 4
The American College of Cardiology recommends using the lowest possible dose to control the underlying condition, considering doses <15 mg/day when feasible, as water retention effects are dose-dependent 2
Dietary salt restriction and potassium supplementation may be necessary, and diuretic therapy may need to be added or adjusted if fluid retention occurs 1, 2, 5, 4